Table 2.
KEGG Pathway | Pathway Name | Normal | CIN2/3 | Cervical Cancer | p a | KEGG Orthology | KO Name | Normal | CIN2/3 | Cervical Cancer | p a |
---|---|---|---|---|---|---|---|---|---|---|---|
ko00550 | Peptidoglycan biosynthesis | 0.8881 | 1.1465 | 2.9481 | 0.0382 | ||||||
ko00300 | Lysine biosynthesis | 0.4785 | 0.5669 | 0.2940 | 0.0084 | K00215 | 4-Hydroxy-tetrahydrodipicolinate reductase | 0.0334 | 0.0380 | 0.0055 | 0.0146 |
K01778 | Diaminopimelate epimerase | 0.0202 | 0.0271 | 0.0036 | 0.0199 | ||||||
ko00680 | Methane metabolism | 0.7161 | 0.7716 | 0.4996 | 0.0049 | K00625 | Phosphate acetyltransferase | 0.0831 | 0.0997 | 0.0407 | 0.0289 |
K01007 | Pyruvate, water dikinase | 0.0203 | 0.0243 | 0.0036 | 0.0361 | ||||||
ko05211 | Renal cell carcinoma | 0.0244 | 0.0327 | 0.0030 | 0.0095 | K01679 | Fumarate hydratase, class II | 0.0284 | 0.0322 | 0.0073 | 0.0318 |
ko05111 | Biofilm formation in Vibrio cholerae | 0.3439 | 0.2532 | 0.1552 | 0.0174 | ||||||
ko00621 | Dioxin degradation | 0.0296 | 0.0204 | 0 | 0.0042 | K01821 | 4-Oxalocrotonate tautomerase | 0.0202 | 0.0167 | 0 | 0.0044 |
ko00362 | Benzoate degradation | 0.1100 | 0.1027 | 0.0421 | 0.0104 | K01821 | 4-Oxalocrotonate tautomerase | 0.0202 | 0.0167 | 0 | 0.0044 |
ko00460 | Cyanoamino acid metabolism | 0.1251 | 0.1093 | 0.0502 | 0.0090 | ||||||
ko00622 | Xylene degradation | 0.0320 | 0.0204 | 0.0044 | 0.0172 | K01821 | 4-Oxalocrotonate tautomerase | 0.0202 | 0.0167 | 0 | 0.0044 |
ko00643 | Styrene degradation | 0.0939 | 0.0596 | 0.0339 | 0.0177 |
ap value calculated by Kruskal–Wallis test.